Tropical Medicine & Surgery

Challenges in Ensuring Effective Rabies Immunization in cats

Rian Gilbert^* Department of Tropical Medicine, University of Amsterdam, Amsterdam, The Netherlands
^*Correspondence: Rian Gilbert, Department of Tropical Medicine, University of Amsterdam, Amsterdam, The Netherlands, Email:

Received: 25-Feb-2025, Manuscript No. TPMS-25-28542; Editor assigned: 27-Feb-2025, Pre QC No. TPMS-25-28542 (PQ); Reviewed: 13-Mar-2025, QC No. TPMS-25-28542; Revised: 20-Mar-2025, Manuscript No. TPMS-25-28542 (R); Published: 27-Mar-2025, DOI: 10.35248/2329-9088.25.13.381

Description

Rabies remains a significant public health concern worldwide, with domestic and wild animals acting as reservoirs for the virus. Vaccination is the most effective method of preventing rabies in cats and reducing transmission to humans and other animals. However, the immune response to primary rabies vaccination in young cats can be influenced by various factors, including age, maternal antibody interference, vaccine type, health status and environmental conditions. Understanding these factors is essential for optimizing vaccination strategies and ensuring longterm immunity.

Age at vaccination

The age at which a cat receives its first rabies vaccine plays a key role in the development of an adequate immune response. Kittens are typically vaccinated at around 12 weeks of age, as earlier administration may lead to suboptimal immunogenicity due to the presence of maternal antibodies. Studies suggest that younger kittens may exhibit lower seroconversion rates compared to those vaccinated at a slightly older age. Ensuring that vaccination schedules align with the waning of maternal antibodies is essential for the effectiveness of primary immunization [1-3] .

Vaccine type and strain

The type and strain of the rabies vaccine used can influence the immune response in young cats. Different vaccines may contain live attenuated, inactivated, or recombinant virus formulations, each with varying immunogenic properties. Inactivated vaccines are most commonly used for rabies prevention in cats due to their safety and effectiveness. Additionally, differences in adjuvant composition can impact immune stimulation. Some adjuvants enhance the immune response, while others may lead to local reactions or potential adverse effects.

Environmental factors and stress

Environmental conditions, including stress levels, can impact the immune response to rabies vaccination. Kittens that experience stress due to overcrowding, transportation, changes in living conditions, or socialization challenges may produce lower antibody levels post-vaccination. Stress-induced immuno suppression can reduce vaccine efficacy by impairing the function of immune cells [4-7].

Booster vaccination and long-term immunity

The longevity of rabies immunity depends on both the initial vaccination and timely booster doses. A single primary vaccination may not provide lifelong protection and booster doses are required to maintain adequate immunity. Most vaccination protocols recommend a booster dose one year after the initial vaccine, followed by additional boosters every one to three years, depending on local regulations and vaccine licensing.

Potential adverse reactions

Although rabies vaccines are generally safe and well-tolerated, some kittens may experience mild side effects such as lethargy, fever, or localized swelling at the injection site. More severe reactions, including allergic responses, are rare but possible. Understanding potential adverse reactions can help veterinarians and pet owners recognize and manage any post-vaccination concerns effectively[8-10] .

Conclusion

The outcome of primary rabies vaccination in young cats is influenced by multiple factors, including age, maternal antibody levels, vaccine type, health status, nutrition, environmental conditions, vaccine handling and genetic variability. Ensuring that kittens receive vaccines at an optimal age, under ideal health conditions and with proper booster follow-ups is essential for achieving strong and lasting immunity. Veterinary professionals and pet owners play a key role in optimizing vaccination strategies, ultimately contributing to effective rabies prevention and public health safety.

References

1. Phadke VK, Gromer DJ, Rebolledo PA, Graciaa DS, Wiley Z, Sherman AC, et al. Safety and immunogenicity of a ChAd155-vectored rabies vaccine compared with inactivated, purified chick embryo cell rabies vaccine in healthy adults. Vaccine. 2024;42(26):126441.

   [Crossref][Google Scholar][PubMed]

2. Oliveira FA, Castro RJ, Silva-Júnior A, Pinheiro RE, Sfaciotte RA, Schwarz DG. Cross-border surveillance of sheep and goat rabies in Brazil. Comp Immunol Microbiol Infect Dis. 2024;113:102233.

   [Crossref][Google Scholar][PubMed]

3. Wobessi JN, Bailly JL, Feussom JM, Njouom R, Sadeuh-Mba SA. Spatiotemporal dynamics of rabies virus detected in rabid dogs in Cameroon, 2010–2021. Infect Genet Evol. 2024;126:105688.

   [Crossref][Google Scholar][PubMed]

4. Ntsama F, Noh SM, Tizzani P, Ntsama CF, Ella GS, Awada L, et al. Identification of risk factors on rabies vaccine efficacy from censored data: Pre-travel tests for dogs and cats from Yaounde (2005–2015). Res Vet Sci. 2024;174:105278.

   [Crossref][Google Scholar][PubMed]

5. Hengtrakool L, Thongratsakul S, Poolkhet C. Spatiotemporal patterns of rabid dogs and cats and the opinions of personnel responsible for disease control in Thailand. Heliyon. 2023;9(11).

   [Crossref][Google Scholar][PubMed]

6. Salgado-Caxito M, Benavides JA, Atero N, Córdova-Bürhle F, Ramos R, Fernandez M, et al. Preventive healthcare among dogs and cats in Chile is positively associated with emotional owner-companion animal bond and socioeconomic factors. Prev Vet Med. 2023;213:105882.

   [Crossref][Google Scholar][PubMed]

7. Marin C, Cerda-Cuellar M, Rosario I, Lorenzo-Rebenaque L, Vega S, Manzanares A, et al. Impact of genetic diversity and antibiotic-resistance of Salmonella isolated from feral cats: One health approach. Comp Immunol Microbiol Infect Dis. 2023;101:102043.

   [Crossref][Google Scholar][PubMed]

8. Yu PC, Dan M, He Y, Meng SL, Yang HY, Su X, et al. A novel mRNA rabies vaccine as a promising candidate for rabies post-exposure prophylaxis protects animals from different rabies viruses. Microb Pathog. 2023;185:106425.

   [Crossref][Google Scholar][PubMed]

9. Huang C, Zhang L, Shan X, Tan S, Ye H, Cao C, et al. Influencing factors and prediction of neutralizing antibodies in post-exposure rabies vaccine recipients. Heliyon. 2024;10(15).

   [Crossref][Google Scholar][PubMed]

10. Bloodworth S, Singleton D, Perkins E, Radford A, Pinchbeck G. Temporal trends and factors associated with vaccination uptake in dogs and cats from 2016 to 2022 in the United Kingdom. Vaccine. 2024;42(22):126185.

    [Crossref][Google Scholar][PubMed]